P
Paniti Sukumvanich
Researcher at University of Pittsburgh
Publications - 92
Citations - 2399
Paniti Sukumvanich is an academic researcher from University of Pittsburgh. The author has contributed to research in topics: Endometrial cancer & Radiation therapy. The author has an hindex of 25, co-authored 75 publications receiving 1965 citations. Previous affiliations of Paniti Sukumvanich include Albert Einstein College of Medicine.
Papers
More filters
Journal ArticleDOI
National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements
Beant S. Gill,J.F. Lin,Thomas C. Krivak,Paniti Sukumvanich,R. Laskey,Malcolm S. Ross,Jamie L. Lesnock,Sushil Beriwal +7 more
TL;DR: Consolidation brachytherapy is a critical treatment component for locally advanced cervical cancer; however, there has been declining utilization of brachyTherapy, and increased use of IMRT and SBRT boost coupled with increased mortality risk should raise concerns about utilizing these approaches over brachyotherapy.
Journal ArticleDOI
Total pelvic exenteration: The Albert Einstein College of Medicine/Montefiore Medical Center Experience (1987 to 2003)
Gary L. Goldberg,Paniti Sukumvanich,Mark H. Einstein,Harriet O. Smith,Patrick Anderson,Abbie L. Fields +5 more
TL;DR: Overall 5-year survival is encouraging, and modifications in surgical technique have improved the reconstructive phase, and TPE remains a potentially curative option for patients with recurrent cervix cancer and pelvic floor reconstruction.
Journal ArticleDOI
USA endometrial cancer projections to 2030: should we be concerned?
M Aamir Sheikh,Andrew D. Althouse,Kyle E. Freese,Sean Soisson,Robert P. Edwards,Sharon C. Welburn,Paniti Sukumvanich,John T. Comerci,Joseph L. Kelley,Ronald E. LaPorte,Faina Linkov +10 more
TL;DR: The projected increase of EC over next 16 years indicates the need for close monitoring of EC trends, and the best-fitting model predicting EC rates projected an increase to 42.13 EC cases per 100,000 by the year 2030.
Journal ArticleDOI
Incidence and time course of bleeding after long-term amenorrhea after breast cancer treatment: a prospective study
Paniti Sukumvanich,L. Doug Case,Kimberly J. Van Zee,S. Eva Singletary,Electra D. Paskett,Jeanne A. Petrek,Elizabeth Naftalis,Michelle J. Naughton +7 more
TL;DR: The incidence of chemotherapy‐induced amenorrhea and the time to subsequent menstrual bleeding in premenopausal breast cancer patients treated with current standard chemotherapy regimens was examined.
Journal ArticleDOI
MRI-Guided High–Dose-Rate Intracavitary Brachytherapy for Treatment of Cervical Cancer: The University of Pittsburgh Experience
Beant S. Gill,Hayeon Kim,Christopher J. Houser,Joseph L. Kelley,Paniti Sukumvanich,Robert P. Edwards,John T. Comerci,Alexander B. Olawaiye,M. Huang,Madeleine Courtney-Brooks,Sushil Beriwal +10 more
TL;DR: This study constitutes one of the largest reported series of MRI-guided brachytherapy in North America, demonstrating excellent local control with acceptable morbidity and may be warranted when feasible for adenocarcinomas to offset the risk of local failure.